Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future

Karla Alfaro; Montserrat Soler; Mauricio Maza; Mauricio Flores; Leticia López; Juan C. Rauda; Andrea Chacón; Patricia Erazo; Nora Villatoro; Eveline Mumenthaler; Rachel Masch; Gabriel Conzuelo; Juan C. Felix; Miriam Cremer

doi:10.3390/cancers14112776

Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future

Karla Alfaro, Montserrat Soler, Mauricio Maza, Mauricio Flores, Leticia López, Juan C. Rauda, Andrea Chacón, Patricia Erazo, Nora Villatoro, Eveline Mumenthaler, Rachel Masch, Gabriel Conzuelo, Juan C. Felix, Miriam Cremer

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Cervical cancer is preventable through vaccination, early detection, and the treatment of pre-cancerous lesions. However, global inequalities mean that the disease remains a leading cause of cancer death around the world, with over 80% of new cases and 90% of deaths occurring in low-and middle-income countries (LMICs). In El Salvador, joint efforts between the Ministry of Health (MoH) and the non-profit organization Basic Health International (BHI) have been in place since 2008, with the goal of reducing the country’s disease burden. While the World Health Organization’s (WHO) call to action to eliminate cervical cancer provided worldwide momentum to implement new public health initiatives, the COVID-19 pandemic disrupted ongoing programs and jeopardized plans for the future. The purpose of this manuscript is to describe the progress that El Salvador has achieved in improving cervical cancer prevention, the impact of the pandemic on current strategies, and potential solutions that can help the country meet the WHO’s strategic targets by 2030 to accelerate the elimination of cervical cancer.

Original language	English
Article number	2776
Journal	Cancers
Volume	14
Issue number	11
DOIs	https://doi.org/10.3390/cancers14112776
State	Published - 1 Jun 2022
Externally published	Yes

Keywords

El Salvador
cervical cancer
cervical pre-cancer
human papillomavirus (HPV)
screen-and-treat

Access to Document

10.3390/cancers14112776

Cite this

@article{3757ce02d9f947928d2635de2cda1aa6,

title = "Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future",

abstract = "Cervical cancer is preventable through vaccination, early detection, and the treatment of pre-cancerous lesions. However, global inequalities mean that the disease remains a leading cause of cancer death around the world, with over 80% of new cases and 90% of deaths occurring in low-and middle-income countries (LMICs). In El Salvador, joint efforts between the Ministry of Health (MoH) and the non-profit organization Basic Health International (BHI) have been in place since 2008, with the goal of reducing the country{\textquoteright}s disease burden. While the World Health Organization{\textquoteright}s (WHO) call to action to eliminate cervical cancer provided worldwide momentum to implement new public health initiatives, the COVID-19 pandemic disrupted ongoing programs and jeopardized plans for the future. The purpose of this manuscript is to describe the progress that El Salvador has achieved in improving cervical cancer prevention, the impact of the pandemic on current strategies, and potential solutions that can help the country meet the WHO{\textquoteright}s strategic targets by 2030 to accelerate the elimination of cervical cancer.",

keywords = "El Salvador, cervical cancer, cervical pre-cancer, human papillomavirus (HPV), screen-and-treat",

author = "Karla Alfaro and Montserrat Soler and Mauricio Maza and Mauricio Flores and Leticia L{\'o}pez and Rauda, {Juan C.} and Andrea Chac{\'o}n and Patricia Erazo and Nora Villatoro and Eveline Mumenthaler and Rachel Masch and Gabriel Conzuelo and Felix, {Juan C.} and Miriam Cremer",

note = "Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2022",

month = jun,

day = "1",

doi = "10.3390/cancers14112776",

language = "English",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "11",

}

TY - JOUR

T1 - Cervical Cancer Prevention in El Salvador

T2 - Gains to Date and Challenges for the Future

AU - Alfaro, Karla

AU - Soler, Montserrat

AU - Maza, Mauricio

AU - Flores, Mauricio

AU - López, Leticia

AU - Rauda, Juan C.

AU - Chacón, Andrea

AU - Erazo, Patricia

AU - Villatoro, Nora

AU - Mumenthaler, Eveline

AU - Masch, Rachel

AU - Conzuelo, Gabriel

AU - Felix, Juan C.

AU - Cremer, Miriam

PY - 2022/6/1

Y1 - 2022/6/1

N2 - Cervical cancer is preventable through vaccination, early detection, and the treatment of pre-cancerous lesions. However, global inequalities mean that the disease remains a leading cause of cancer death around the world, with over 80% of new cases and 90% of deaths occurring in low-and middle-income countries (LMICs). In El Salvador, joint efforts between the Ministry of Health (MoH) and the non-profit organization Basic Health International (BHI) have been in place since 2008, with the goal of reducing the country’s disease burden. While the World Health Organization’s (WHO) call to action to eliminate cervical cancer provided worldwide momentum to implement new public health initiatives, the COVID-19 pandemic disrupted ongoing programs and jeopardized plans for the future. The purpose of this manuscript is to describe the progress that El Salvador has achieved in improving cervical cancer prevention, the impact of the pandemic on current strategies, and potential solutions that can help the country meet the WHO’s strategic targets by 2030 to accelerate the elimination of cervical cancer.

AB - Cervical cancer is preventable through vaccination, early detection, and the treatment of pre-cancerous lesions. However, global inequalities mean that the disease remains a leading cause of cancer death around the world, with over 80% of new cases and 90% of deaths occurring in low-and middle-income countries (LMICs). In El Salvador, joint efforts between the Ministry of Health (MoH) and the non-profit organization Basic Health International (BHI) have been in place since 2008, with the goal of reducing the country’s disease burden. While the World Health Organization’s (WHO) call to action to eliminate cervical cancer provided worldwide momentum to implement new public health initiatives, the COVID-19 pandemic disrupted ongoing programs and jeopardized plans for the future. The purpose of this manuscript is to describe the progress that El Salvador has achieved in improving cervical cancer prevention, the impact of the pandemic on current strategies, and potential solutions that can help the country meet the WHO’s strategic targets by 2030 to accelerate the elimination of cervical cancer.

KW - El Salvador

KW - cervical cancer

KW - cervical pre-cancer

KW - human papillomavirus (HPV)

KW - screen-and-treat

UR - http://www.scopus.com/inward/record.url?scp=85131173782&partnerID=8YFLogxK

U2 - 10.3390/cancers14112776

DO - 10.3390/cancers14112776

M3 - Article

AN - SCOPUS:85131173782

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 11

M1 - 2776

ER -

Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future

Abstract

Keywords

Access to Document

Fingerprint

Cite this